9 completed. 9 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 9 |
| Phase 3 | 1 | Completed 1 |
Follow FG-4592: new trials by email Literature Review of FG-4592 trials Research Report on FG-4592
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia Roxadustat - Chemotherapy Induced Anemia | Phase 2 | Completed | Kyntra Bio | 92 | 2019-08-20 | 2022-06-03 |
| Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS) FG-4592, Placebo - Anemia, Myelodysplastic Syndrome | Phase 2 / Phase 3 | Completed | Kyntra Bio | 43 | 2018-06-06 | 2023-05-03 |
| Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease Roxadustat - Chronic Kidney Disease, End Stage Renal Disease | Phase 2 | Completed | Kyntra Bio | 15 | 2012-05-18 | 2021-10-01 |
| Study of FG-4592 in Subjects With Chronic Kidney Disease in China FG-4592, Placebo - Anemia in Chronic Kidney Disease | Phase 2 | Completed | Kyntra Bio | 91 | 2011-12-01 | 2014-03-03 |
| Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China FG-4592, Epoetin Alfa - Anemia in End Stage Renal Disease | Phase 2 | Completed | Kyntra Bio | 96 | 2011-09-01 | 2013-02-04 |
| Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment Roxadustat, Oral Iron, IV Iron - Dialysis, Anemia | Phase 2 | Completed | Kyntra Bio | 60 | 2011-07-21 | 2021-10-01 |
| Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia Roxadustat - Chronic Kidney Disease, Anemia | Phase 2 | Completed | Kyntra Bio | 145 | 2010-10-29 | 2022-02-10 |
| Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis Roxadustat, Epoetin Alfa, Placebo - End Stage Renal Disease, Anemia | Phase 2 | Completed | Kyntra Bio | 161 | 2010-05-17 | 2022-01-11 |
| Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis Roxadustat, Placebo - Chronic Kidney Disease, Anemia | Phase 2 | Completed | Kyntra Bio | 117 | 2006-11-01 | 2021-11-19 |
Anemia (9) · Renal Insufficiency, Chronic (4) · Kidney Failure, Chronic (3) · Myelodysplastic Syndromes (1)
Kyntra Bio (9)
United States (6) · China (3) · Puerto Rico (2) · Hong Kong (1) · Russia (1) · Singapore (1)
Marietta Franco (1) · Peony Yu (1)